BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 25677850)

  • 21. Modeling the binding mechanism of Alzheimer's Aβ1-42 to nicotinic acetylcholine receptors based on similarity with snake α-neurotoxins.
    Maatuk N; Samson AO
    Neurotoxicology; 2013 Jan; 34():236-42. PubMed ID: 23022323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural features of angiotensin-I converting enzyme catalytic sites: conformational studies in solution, homology models and comparison with other zinc metallopeptidases.
    Spyroulias GA; Galanis AS; Pairas G; Manessi-Zoupa E; Cordopatis P
    Curr Top Med Chem; 2004; 4(4):403-29. PubMed ID: 14965309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteolytic release of membrane-bound angiotensin-converting enzyme: role of the juxtamembrane stalk sequence.
    Ehlers MR; Schwager SL; Scholle RR; Manji GA; Brandt WF; Riordan JF
    Biochemistry; 1996 Jul; 35(29):9549-59. PubMed ID: 8755736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxidative balance in Alzheimer's disease: relationship to APOE, Braak tangle stage, and the concentrations of soluble and insoluble amyloid-β.
    Tayler H; Fraser T; Miners JS; Kehoe PG; Love S
    J Alzheimers Dis; 2010; 22(4):1363-73. PubMed ID: 20930272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin-converting enzyme as a potential target for treatment of Alzheimer's disease: inhibition or activation?
    Zou K; Michikawa M
    Rev Neurosci; 2008; 19(4-5):203-12. PubMed ID: 19145983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurotoxic Effects of Aβ6-42 Peptides Mimicking Putative Products Formed by the Angiotensin Converting Enzyme.
    Medvedev AE; Radko SP; Yurinskaya MM; Vinokurov MG; Buneeva OA; Kopylov AT; Kozin SA; Mitkevich VA; Makarov AA
    J Alzheimers Dis; 2018; 66(1):263-270. PubMed ID: 30282362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitory antibodies to human angiotensin-converting enzyme: fine epitope mapping and mechanism of action.
    Skirgello OE; Balyasnikova IV; Binevski PV; Sun ZL; Baskin II; Palyulin VA; Nesterovitch AB; Albrecht RF; Kost OA; Danilov SM
    Biochemistry; 2006 Apr; 45(15):4831-47. PubMed ID: 16605251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiotensin-converting enzyme (ACE) levels and activity in Alzheimer's disease, and relationship of perivascular ACE-1 to cerebral amyloid angiopathy.
    Miners JS; Ashby E; Van Helmond Z; Chalmers KA; Palmer LE; Love S; Kehoe PG
    Neuropathol Appl Neurobiol; 2008 Apr; 34(2):181-93. PubMed ID: 17973905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of new Presenilin-1 phosphosites: implication for γ-secretase activity and Aβ production.
    Matz A; Halamoda-Kenzaoui B; Hamelin R; Mosser S; Alattia JR; Dimitrov M; Moniatte M; Fraering PC
    J Neurochem; 2015 May; 133(3):409-21. PubMed ID: 25458374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening of ACE-inhibitory peptides from a random peptide-displayed phage library using ACE-coupled liposomes.
    Kumada Y; Hashimoto N; Hasan F; Terashima M; Nakanishi K; Jungbauer A; Katoh S
    J Biotechnol; 2007 Aug; 131(2):144-9. PubMed ID: 17658644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Positional-scanning combinatorial libraries of fluorescence resonance energy transfer peptides for defining substrate specificity of the angiotensin I-converting enzyme and development of selective C-domain substrates.
    Bersanetti PA; Andrade MC; Casarini DE; Juliano MA; Nchinda AT; Sturrock ED; Juliano L; Carmona AK
    Biochemistry; 2004 Dec; 43(50):15729-36. PubMed ID: 15595828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perindopril, a centrally active angiotensin-converting enzyme inhibitor, prevents cognitive impairment in mouse models of Alzheimer's disease.
    Dong YF; Kataoka K; Tokutomi Y; Nako H; Nakamura T; Toyama K; Sueta D; Koibuchi N; Yamamoto E; Ogawa H; Kim-Mitsuyama S
    FASEB J; 2011 Sep; 25(9):2911-20. PubMed ID: 21593435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Naturally occurring angiotensin I-converting enzyme inhibitory peptide from a fertilized egg and its inhibitory mechanism.
    Duan X; Wu F; Li M; Yang N; Wu C; Jin Y; Yang J; Jin Z; Xu X
    J Agric Food Chem; 2014 Jun; 62(24):5500-6. PubMed ID: 24866326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Solid-phase synthesis and conformational properties of angiotensin converting enzyme catalytic-site peptides: the basis for a structural study on the enzyme-substrate interaction.
    Galanis AS; Spyroulias GA; Pairas G; Manessi-Zoupa E; Cordopatis P
    Biopolymers; 2004; 76(6):512-26. PubMed ID: 15508121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. β-Amyloid and neprilysin computational studies identify critical residues implicated in binding specificity.
    Pope D; Madura JD; Cascio M
    J Chem Inf Model; 2014 Apr; 54(4):1157-65. PubMed ID: 24650257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (A beta ); retards A beta aggregation, deposition, fibril formation; and inhibits cytotoxicity.
    Hu J; Igarashi A; Kamata M; Nakagawa H
    J Biol Chem; 2001 Dec; 276(51):47863-8. PubMed ID: 11604391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amyloid beta peptide-degrading microbial enzymes and its implication in drug design.
    Dhanavade MJ; Sonawane KD
    3 Biotech; 2020 Jun; 10(6):247. PubMed ID: 32411571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simulated interactions between angiotensin-converting enzyme and substrate gonadotropin-releasing hormone: novel insights into domain selectivity.
    Papakyriakou A; Spyroulias GA; Sturrock ED; Manessi-Zoupa E; Cordopatis P
    Biochemistry; 2007 Jul; 46(30):8753-65. PubMed ID: 17605472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual effects of familial Alzheimer's disease mutations (D7H, D7N, and H6R) on amyloid β peptide: correlation dynamics and zinc binding.
    Xu L; Chen Y; Wang X
    Proteins; 2014 Dec; 82(12):3286-97. PubMed ID: 25137638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Copper(I) and copper(II) inhibit Aβ peptides proteolysis by insulin-degrading enzyme differently: implications for metallostasis alteration in Alzheimer's disease.
    Grasso G; Pietropaolo A; Spoto G; Pappalardo G; Tundo GR; Ciaccio C; Coletta M; Rizzarelli E
    Chemistry; 2011 Feb; 17(9):2752-62. PubMed ID: 21274957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.